Details for New Drug Application (NDA): 018458

✉ Email this page to a colleague

NDA 018458 describes TALACEN, which is a drug marketed by Sanofi Aventis Us and is included in one NDA. Additional details are available on the TALACEN profile page.

The generic ingredient in TALACEN is acetaminophen; pentazocine hydrochloride. There are sixty-six drug master file entries for this compound. Additional details are available on the acetaminophen; pentazocine hydrochloride profile page.

Summary for 018458

Tradename:	TALACEN
Applicant:	Sanofi Aventis Us
Ingredient:	acetaminophen; pentazocine hydrochloride
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	650MG;EQ 25MG BASE
Approval Date:	Sep 23, 1982	TE:		RLD:	No

Expired US Patents for NDA 018458

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sanofi Aventis Us	TALACEN	acetaminophen; pentazocine hydrochloride	TABLET;ORAL	018458-001	Sep 23, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.